Journal profile · PHARMACOLOGY & PHARMACY-PSYCHIATRY
Psychopharmacology bulletin
ISSN 0048-5764 · eISSN 2472-2448 · MedWorks Media LLC · United States · Quarterly · Founded 1966
FollowGet an email when its zone, impact factor or warning status changes
Psychopharmacology bulletin: subscription journal; community-reported acceptance: easy; 558 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Psychopharmacology bulletin is published by MedWorks Media LLC. By OpenAlex counts of its recent articles, its largest topics are Schizophrenia research and treatment, Treatment of Major Depression and Bipolar Disorder and Treatment, together about 47.6% of its articles. Its main subfields are Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)
Psychopharmacology Bulletin publishes full-length research articles, review articles, brief reports, clinical case studies, commentary, and letters. Manuscripts submitted to the journal's Negative and Failed Clinical Trial Reports section are entitled to fast-track review.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY-PSYCHIATRY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Schizophrenia research and treatmentMedicine20.8%
- Treatment of Major DepressionMedicine18%
- Bipolar Disorder and TreatmentMedicine8.7%
- Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychology6.4%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience6.2%
- Electroconvulsive Therapy StudiesMedicine4.5%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics3.5%
- Mental Health Treatment and AccessPsychology3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Psychiatry and Mental Health | Q3 | 363/580 | 37th |
| Pharmacology (medical) | Q3 | 180/278 | 35th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEPubMedEmbaseCurrent ContentsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 2.2LetPub ·
- SJR 2026-06
- 0.46LetPub ·
- SNIP 2026-06
- 0.58LetPub ·
- h-index
- 60LetPub ·
- h-index
- 54OpenAlex ·
- i10-index
- 274OpenAlex ·
- 2-year mean citedness
- 15.95OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 721 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 58 | 58 | 503 |
| 2025 | 558 | 273 | 630 |
| 2024 | 0 | 0 | 668 |
| 2023 | 0 | 0 | 555 |
| 2022 | 0 | 0 | 486 |
| 2021 | 0 | 0 | 579 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Article types accepted9, with length limits
- brief communicationBrief Communication Brief Reports Maximum four printed pages (approximately six double-spaced manuscript pages including text, references, figures, and legends)…Length not stated
- brief reportMaximum four printed pages (approximately six double-spaced manuscript pages including text, references, figures, and legends). Intended for preliminary observa…Length not stated
- clinical studyClinical Study Clinical Case Studies Two to four printed pages (approximately 4-6 manuscript pages including illustrations and tables).Length not stated
- editorialManuscripts must be submitted exclusively to Psychopharmacology Bulletin and cannot have been published elsewhere in any format. Editorial Board members review …Length not stated
- expert commentaryExpert Commentary Letters to the Editor Letters facilitate rapid communication of novel observations or important research findings.Length not stated
- letters to the editorLetters facilitate rapid communication of novel observations or important research findings. Commentary on published Psychopharmacology Bulletin articles is wel…main text ≤ 1,000 words
- original researchOriginal Research Research Articles No page or figure restrictions apply.Length not stated
- review articleUsually invited but submitted reviews are considered. Provide critical review and interpretation of literature and current research directions. Include abstract…Length not stated
- systematic reviewSystematic Review Review Articles Usually invited but submitted reviews are considered.Length not stated
Policy excerpts from the journal's websiteConflicts of interest, License & copyright, Open access, Peer review, Preprints
- Conflicts of interest Conflict of Interest & Responsibility
Authors must clearly indicate any potential conflicts of interest, financial or otherwise, in the manuscript or cover letter. All published statements and omissions remain the author's responsibility. Authors will review proofs prior to publication, and reprint order forms accompany page proofs. No page charges apply for publication in Psychopharmacology Bulletin.
Source ↗Publisher website ·- License & copyright
Copyright transfer agreement required upon acceptance. Model summary
Upon acceptance, the corresponding author must sign a copyright transfer agreement.
Source ↗Publisher website ·- Open access Open Access
No page charges. Model summary
To support Open Access research, each issue of Psychopharmacology Bulletin designates select articles as Open Access. These articles are available for free download, with PubMed links directing readers to the journal's portal for complimentary access. For more information, contact the publisher at ceo@medworksmedia.com.
Source ↗Publisher website ·- Peer review Editorial Review Process
Double-blind peer review Model summary
Manuscripts must be submitted exclusively to Psychopharmacology Bulletin and cannot have been published elsewhere in any format. Editorial Board members review submissions based on topic and focus. The journal assumes no responsibility for manuscript loss at any stage. Upon acceptance, the corresponding author must sign a copyright transfer agreement. All accepted manuscripts become publisher prop…
Source ↗Publisher website ·- Preprints
Exclusivity: manuscripts must not be published elsewhere. Model summary
Manuscripts must be submitted exclusively to Psychopharmacology Bulletin and cannot have been published elsewhere in any format.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Before you submit
Three checks before submitting to Psychopharmacology bulletin
- 1ScopeRecent output centres on Schizophrenia research and treatment, Treatment of Major Depression.Check scope
- 2Article type and formatAbstract: ≤ 250 words.Submission rules
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- MedWorks Media LLC
- Country or region
- United States
- Frequency
- Quarterly
- Founded
- 1966
- ISSN
- 0048-5764
- Print ISSN
- 2472-2448
- Electronic ISSN
- 2472-2448
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about Psychopharmacology bulletin
Which databases index Psychopharmacology bulletin?
According to LetPub and DOAJ records, Psychopharmacology bulletin is indexed in Scopus. The journal's website also lists SCIE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Psychopharmacology bulletin open access, and what is the APC?
Psychopharmacology bulletin is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .